| IMMUCELL CORP. DL-,10 |
| USA |
| Gesundheit |
| US4525253062 / 885825 |
| IUL (Frankfurt) / ICCC (NASDAQ) |
| FRA:IUL, ETR:IUL, IUL:GR, NASDAQ:ICCC |
| - |
| https://immucell.com/ |
|
ImmuCell Corporation is a biotechnology company engaged in the development, manufacture, and sale of products that improve animal health and productivity in the dairy and beef industries. The company's primary focus is on the development of products ..
>Volltext.. |
| 50.47 Mio. EUR |
| 47.17 Mio. EUR |
| 23.95 Mio. EUR |
| 3.8 Mio. EUR |
| -0.9 Mio. EUR |
| -0.1 EUR |
| - |
| - |
| 2.14 Mio. EUR |
| - |
| 4.35% |
| 51.77% |
| - |
| - |
| - |
| - |
| IMMUCELL |
| 05.04.26 |
|